Product Information

ATORVASTATIN 80 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0669 per EA under NDC 00904629304. Its NADAC has been published 617 times since Jan 28, 2015.

FDA first approved this application on May 29, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the ATORVASTATIN CALCIUM market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ATORVASTATIN 80 MG TABLET

ATORVASTATIN CALCIUM
$0.0669per EA
Low Outlier

Strength

80 mg/1

NDC

00904629304

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA090548

FDA Approved

5/29/2012

TE Code

AB

On Market Since

10/31/2014

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for ATORVASTATIN 80 MG TABLET has been published 617 times since Jan 28, 2015, and over the history we have for it it has declined 61.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0669 per EA
All-time high$0.1996 (Apr 15, 2015)
All-time low$0.0635 (Jul 17, 2024)
52-week high$0.0726
52-week low$0.0669
Median price$0.1207
Average price$0.1177
Largest weekly change-25.7% (Jul 17, 2024)
Weeks tracked617
Tracking sinceJan 28, 2015

Price History

1W

-1.6%

1M

-3.4%

3M

-3.4%

6M

-5.2%

1Y

-6.0%

3Y

-21.6%

5Y

-31.5%

All

-61.9%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ATORVASTATIN 80 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 80 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0669 per EA (NDC 00904629304), effective Nov 18, 2026.

How has the price of ATORVASTATIN 80 MG TABLET changed over time?

Over the history we have for it, the NADAC for ATORVASTATIN 80 MG TABLET has declined 61.9%. It has been tracked across 617 weekly CMS publications since Jan 28, 2015.

What are the highest and lowest recorded NADAC prices for ATORVASTATIN 80 MG TABLET?

Since Jan 28, 2015, the NADAC for ATORVASTATIN 80 MG TABLET has ranged from a low of $0.0635 (Jul 17, 2024) to a high of $0.1996 (Apr 15, 2015), with a median of $0.1207 per EA.

Are there cheaper alternatives to ATORVASTATIN 80 MG TABLET?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATORVASTATIN 80 MG TABLET, is $0.0635 per EA — about 5% below ATORVASTATIN 80 MG TABLET.

Who manufactures ATORVASTATIN 80 MG TABLET?

ATORVASTATIN 80 MG TABLET (NDC 00904629304) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.